Boston, MA (PRWEB) October 05, 2015
FDNA, a pioneer in computer-aided dysmorphology analysis, invites geneticists from around the world to join the second cycle of the “GIVE A FACE TO A SYNDROME” research program. The date of the release coincides with the American Association of Human Genetics annual meeting, ASHG 2015, in Baltimore, MD, where attendees can receive more details at booth #915.
The Facial Dysmorphology Novel Analysis (FDNA®) technology, powering Face2Gene, a neurogenetic search and reference solution that facilitates detection of facial dysmorphic features and recognizable patterns of human malformations to present comprehensive and up-to-date neurogenetic references will also be the center of this research program. Taking part in the GIVE A FACE TO A SYNDROME program enables geneticist to use the FDNA technology for free, to leverage the support of a dedicated research team and to utilize FDNA’s tens of thousands of dysmorphology related data‐points.
"We are proud to make FDNA’s technology and our de-identified research data available to geneticists to advance genetic research. Being able to securely analyze their own research data and compare it with tens of thousands of data points processed by us, will allow researchers to identify unique phenotype / genotype correlations and increase knowledge for the benefit of the genetics expert community.“ said Dekel Gelbman, FDNA's Chief Executive Officer. "After receiving overwhelming responses to our first research cycle, we are thrilled to launch the second cycle of this research program at ASHG 2015,” continued Gelbman.
Individuals and institutions interested in joining the second cycle of the GIVE A FACE TO A SYNDROME research program should submit a short proposal by 5:00 PM Eastern time on December 31, 2015 . The call for research proposals is available to all registered Face2Gene users worldwide and does not include financial support. Study results will be shared with the scientific community and may serve as the basis for scientific publication by the collaborators. Collaborators will receive full credit for their participation in the program. Applicants are invited to submit proposals in this link http://www.FDNA.com/Cycle2
FDNA's mission is to save lives and improve the quality of life of patients with rare or difficult-to-diagnose genetic syndromes. FDNA has developed the proprietary Facial Dysmorphology Novel Analysis (FDNA®) technology. This cutting-edge technology facilitates the detection of facial dysmorphic features and recognizable patterns of human malformations from facial photos. For more information, please visit http://www.FDNA.com